Related Experiment Video
Updated: Mar 18, 2026

The Plant Infection Test: Spray and Wound-Mediated Inoculation with the Plant Pathogen Magnaporthe Grisea
Published on: August 4, 2018
A Conserved Magnaporthe oryzae Effector Counteracts the Rice Ubiquitin-Proteasome System by Disrupting the E2
Min Wang1,2, Ruyi Wang1, Yehui Xiong3
1State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.
None:
Pathogens commonly secrete effectors into host cells to facilitate invasion. In the host ubiquitin-proteasome system (UPS), E3 ubiquitin ligases often target pathogen effectors for degradation, thereby enhancing immune responses. In turn, pathogen effectors frequently disrupt E3 ligase function to promote virulence. However, it remains largely unclear whether pathogen effectors also interfere with other enzymes of the UPS, such as E2 ubiquitin-conjugating enzymes. In this study, we identified a conserved effector, MoCE1, that is essential for the pathogenicity of Magnaporthe oryzae. MoCE1 is secreted into rice cells, where it interacts with the rice E3 ligase OsRING10 and the E2 enzyme OsUBC11. Upon M. oryzae infection, OsRING10 and OsUBC11 act synergistically to degrade MoCE1 through K48-linked polyubiquitination. Overexpression of either OsRING10 or OsUBC11 enhances resistance to M. oryzae. To counteract this defence, MoCE1 inhibits the enzymatic activity of OsUBC11. Collectively, these findings reveal a nuanced mechanism in which a pathogen effector, regulated by a host E2-E3 pair, disrupts E2 function to escape UPS-mediated immunity in plants.
More Related Videos
Related Concept Videos
Experimental RNAi
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
Stringent Response in E. coli
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

